Mu-opioid receptor (MOR) is overexpressed in many cancer types versus normal tissue[1–10] and its activation appears to facilitate VEGF induced angiogenesis [11•, 12], to increase vascular permeability and to blunt immune response [13, 14]. This evidence concerns the gene OPRM1 and cancer.